Latest Leverage News

Anteris Technologies has gained U.S. Medicare reimbursement eligibility for its pivotal PARADIGM Trial, clearing a key hurdle for clinical site activation and accelerating its transcatheter heart valve study.

Tyranna Resources has identified new gold anomalies at its Chinguar Gold Project and progressed licence security and bulk sampling plans at its Namibe Lithium and Caesium Project in Angola.

Acrux pivots from generics to developing a Female Testosterone therapy for HSDD, leveraging FDA feedback and a strong US market opportunity.

Lake Resources made solid progress on the Exploitation Environmental Impact Assessment for its Kachi Lithium Brine Project, targeting approval in Q3 2026, while maintaining strong liquidity and strategic partnerships.

Atomo Diagnostics capitalises on Lumos Diagnostics’ FebriDx FDA CLIA waiver with over $2 million in new sales orders and a $3 million capital raise, expanding its global footprint and product pipeline.

CONNEQT Health’s Pulse device sales surged to a $7 million annualised run-rate despite a temporary supply hiccup, while the company manages a tight cash runway supported by new R&D loans and related-party funding.

Rakon Limited has swung back to profit in FY26, reporting a 24% revenue lift and doubling EBITDA, while Bourns' takeover offer edges closer to completion with 85% shareholder acceptance and pending French regulatory approval.

Axtec Limited has sold its PaySure loan book to Real Flow and secured a minority stake in the fintech, marking a strategic shift towards a platform-focused, AI-driven distribution model.

Osmond Resources has released final assays from its Phase 1 drilling at the Orión EU Critical Minerals Project in Spain, revealing significant enrichment of titanium, zirconium, and rare earth elements over a 10km strike. The discovery of a new basal mineralised seam adds to the project's scale, with Phase 2 drilling imminent and a Scoping Study targeted for late 2026.

Nexsen Limited has cleared a major FDA regulatory hurdle for its StrepSure rapid Group B Streptococcus test, confirmed a clear 510(k) submission pathway, and secured over A$1.7 million in non-dilutive grants to expand clinical validation and market rollout in Asia-Pacific and neonatal diagnostics.

PhosCo Ltd advances its Gasaat Phosphate Project with robust drilling results at KM and SAB deposits, confirming thick, high-grade mineralisation. Imminent maiden resource estimates and a significant new discovery at DOH underscore the project's growing global significance amid supply chain disruptions.

Red Metal Limited is progressing key rare earth and base metal projects across Australia, securing government grants and proposing a major Maronan Metals share distribution to shareholders.